UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

The New England journal of medicine, 2019-12, Vol.381 (26), p.2506-2518

2019

Volltextzugriff (PDF)

Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates-A Comprehensive Statistical Analysis

Cancers, 2022-11, Vol.14 (21), p.5447

2022

Volltextzugriff (PDF)

A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Cancer, 2009-07, Vol.115 (13), p.2881-2890

2009

Volltextzugriff (PDF)

Adult Granulosa Cell Tumor of the Testis: A Case Report with a Review of the Literature

Case reports in urology, 2019, Vol.2019 (2019), p.1-10

2019

Volltextzugriff (PDF)

Revised manuscript R2, clean version are serum levels of 25-hydroxy vitamin D reduced following orchiectomy in testicular cancer patients?

Basic and clinical andrology, 2021-06, Vol.31 (1), p.14-14, Article 14

2021

Volltextzugriff (PDF)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1412-1423

2019

Volltextzugriff (PDF)

Patient events in German urology: trend towards hybrid formats?

Urologie (Heidelberg, Germany), 2024-01, Vol.63 (1), p.75-82

2024

Volltextzugriff (PDF)

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany

PloS one, 2023-05, Vol.18 (5), p.e0286309-e0286309

2023

Volltextzugriff (PDF)

Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease

Japanese journal of clinical oncology, 2021-08, Vol.51 (8), p.1287-1297

2021

Volltextzugriff (PDF)

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin

Journal of cancer research and clinical oncology, 2021-02, Vol.147 (2), p.435-443

2021

Volltextzugriff (PDF)

Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer

Clinical cancer research, 2004-04, Vol.10 (7), p.2393-2400

2004

Volltextzugriff (PDF)

Chancen und Risiken der Telemedizin in der Urologie

Urologe. Ausgabe A, 2022-02, Vol.61 (2), p.117-124

Wülfing, Christian

2022

Volltextzugriff (PDF)

Familial Testicular Germ Cell Tumor in Two Brothers With Emery Dreifuss Muscular Dystrophy Caused by an FHL-1 Mutation: A Case Report

Curēus (Palo Alto, CA), 2023-05

2023

Volltextzugriff (PDF)

Myoid gonadal stromal tumor of the testis-the novel subtype of testicular gonadal stromal tumors: a case report and review of the literature

Journal of medical case reports, 2024-02, Vol.18 (1), p.71-71, Article 71

2024

Volltextzugriff (PDF)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1

World journal of urology, 2022-02, Vol.40 (2), p.317-326

2022

Volltextzugriff (PDF)

Expression of Endothelin-1, Endothelin-A, and Endothelin-B Receptor in Human Breast Cancer and Correlation with Long-Term Follow-Up

Clinical cancer research, 2003-09, Vol.9 (11), p.4125-4131

2003

Volltextzugriff (PDF)

CTC counts as a biomarker of prognosis and response in metastatic castration-resistant prostate cancer (mCRPC) from the CARD trial

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.161-161

2021

Volltextzugriff (PDF)

Unilateral, Small, Benign, Late-Onset, Large-Cell Calcifying Sertoli Cell Tumor: A Case Report

Curēus (Palo Alto, CA), 2023-07

2023

Volltextzugriff (PDF)

Tertiary Syphilitic Gumma Mimicking Testicular Neoplasms

Curēus (Palo Alto, CA), 2023-04

2023

Volltextzugriff (PDF)

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma

Frontiers in oncology, 2022-05, Vol.12, p.889624-889624

2022

Volltextzugriff (PDF)

Organerhaltende Verfahren zur Therapie des Nierenzellkarzinoms: Operative Techniken, ablative Therapien und „Active Surveillance

Der Klinikarzt, 2017-09, Vol.46 (9), p.424-428

Wülfing, Christian

2017

Volltextzugriff (PDF)

Urologische Themenwoche Hodenkrebs

Uro-news, 2017-06, Vol.21 (6), p.24-25

Wülfing, Christian

2017

Volltextzugriff (PDF)

CARD: Overall survival (OS) analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel versus abiraterone or enzalutamide

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5569-5569

2020

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(127)
Deutsch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates-A Comprehensive Statistical Analysis

A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05)

Adult Granulosa Cell Tumor of the Testis: A Case Report with a Review of the Literature

Revised manuscript R2, clean version are serum levels of 25-hydroxy vitamin D reduced following orchiectomy in testicular cancer patients?

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Patient events in German urology: trend towards hybrid formats?

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany

Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin

Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer

Chancen und Risiken der Telemedizin in der Urologie

Familial Testicular Germ Cell Tumor in Two Brothers With Emery Dreifuss Muscular Dystrophy Caused by an FHL-1 Mutation: A Case Report

Myoid gonadal stromal tumor of the testis-the novel subtype of testicular gonadal stromal tumors: a case report and review of the literature

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1

To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic

Expression of Endothelin-1, Endothelin-A, and Endothelin-B Receptor in Human Breast Cancer and Correlation with Long-Term Follow-Up

CTC counts as a biomarker of prognosis and response in metastatic castration-resistant prostate cancer (mCRPC) from the CARD trial

Unilateral, Small, Benign, Late-Onset, Large-Cell Calcifying Sertoli Cell Tumor: A Case Report

Tertiary Syphilitic Gumma Mimicking Testicular Neoplasms

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma

Organerhaltende Verfahren zur Therapie des Nierenzellkarzinoms: Operative Techniken, ablative Therapien und „Active Surveillance

Urologische Themenwoche Hodenkrebs

CARD: Overall survival (OS) analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel versus abiraterone or enzalutamide

Suchergebnisse filtern